Previous 10 | Next 10 |
Medicare Advantage patients with diabetes in the agilon model saw 2-3 times greater improvement of Hemoglobin A1c control and other measures compared to Medicare Advantage and Medicare Fee-for-Service benchmarks Patients with diabetes with consistent Hemoglobin A1c control achieved statis...
Joseph Eid M.D., is a US certified medical oncologist with extensive experience of the use of biomarkers in clinical trials and as companion diagnostics Previous roles include senior positions in oncology at Bristol Myers Squibb, Merck & Co. and Hoffman-La Roche GUILDFORD, SURREY / A...
GUILDFORD, SURREY / ACCESSWIRE / January 11, 2023 / TR-1: Standard form for notification of major holdings This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the Un...
Summary I believe the current US healthcare setup is not ideal for stakeholders. The agilon health platform offers a compelling value proposition to stakeholders. Reaffirmation of FY22 EBITDA guidance is a positive indicator. Recommendation The buy case for agilon heal...
agilon health ( NYSE: AGL ) added ~13% on Monday after the healthcare service provider for seniors increased its preliminary Medicare Advantage outlook to more than ~400K members in 2023, up from the ~390K in the previous guidance. In a regulatory filing issued ahead of its presen...
agilon health, inc. (AGL) Q3 2022 Results Conference Call November 03, 2022 05:00 PM ET Company Participants Matthew Gillmor - VP, IR Steve Sell - CEO Tim Bensley - CFO Conference Call Participants Lisa Gill - JP Morgan Justin Lake - Wolfe Researc...
agilon health press release ( NYSE: AGL ): Q3 GAAP EPS of -$0.07 misses by $0.02 . Revenue of $695M (+51.4% Y/Y) beats by $41.62M . Medicare Advantage membership increased 45% to 266,600, and Medical Margin increased 74% to $76 million Total members l...
Revenue increased 52% to $695 million, Medicare Advantage membership increased 45% to 266,600, and Medical Margin increased 74% to $76 million Total members live on the agilon platform grew to 356,000, including 266,600 Medicare Advantage members and 89,400 Direct Contra...
agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will release its financial results for the third quarter 2022 after the market closes on Thursday, November 3, 2022, and host a conference call at 5:...
Summary Cano Health currently presents an interesting investment opportunity with a potential short-term 58% upside. Recently, rumors appeared that Cano Health has received acquisition interest, with healthcare industry giants CVS Health, Humana and UnitedHealth among the rumored ...
News, Short Squeeze, Breakout and More Instantly...
agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will release its financial results for the second quarter 2024 after the market closes on Tuesday, August 6, 2024, and host a conference call at 4:30 PM Easter...
Dr. Rao to Continue to Lead Clinical Strategy and Drive Physician Network Performance Alongside agilon’s Chief Clinical Officer Kevin Spencer, M.D. agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced ...
2024-07-07 00:56:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...